CPHI South East Asia’s Post

You’ve probably heard the saying, “If you want to go fast, go alone. If you want to go far, go with others”. Nothing could be truer about epiAge!   Initially, of course, as a bootstrapped start-up, we might not have had much of a choice but to grow a network slowly but steadily. However, looking back at 3 exciting years, we cannot help but wonder at our 30+ resellers (6 of them joined us over the course of the spring), not to mention the 100+ medical doctors (many new faces here too!) and 10 clinics spread over 7 countries – many of which can be accessed through our medical consultation network. A particular milestone has been securing the cooperation of the ias PREVENT Group, a medical organisation offering comprehensive health check-ups in 7 German cities, with whom we have been successfully working for the past couple of years.    If epiAge is now thriving, it is thanks to tireless networking efforts with highly professional physicians and medical institutions as well as quality nutraceutical companies. We are proud of all these individuals and organisations who have put their trust in our eminently reliable longevity tool!   But now it is time to build on all these great collaborations and move on to the next level. We want to establish a brand-new model of health prevention. So, stay tuned: there are momentous developments in the making …   #biologicalage #longevity #network

Here are some practical pointers for Medical Affairs and Product Development professionals.

Attended a wonderful ABMH pharmacon - 2023 "8th national conference" on December 2nd and 3rd. Very thankful to Organisation, Organisers and team to bring such imminent speakers from different domains across different domains namely Dr.Atmaram Pawar, Dr Lalit Kanodia, Dr.Anup Warrier, Dr. Chandrakant Kokate, Dr.Bikash Medhi. It was such Informative and scale-up session with discussion on various topics such as 1. Clinical Pharmacy practise: Global and Indian scenario 2. Recent advancement in procurement management 3. Optimizing Antibiotic use stewardship 4. Pharmacists role in PvPI and MvPI 5. New concepts of nutraceuticals 6. Role of accreditation in medication management 7. Fixed dose combination:Indian scenario 8. Pharmacogenomics basic to Clinical practice 9. Legal aspects of hospital and pharmacy

🔹✨ CE Sunday: Elevating Pharmacy Practice! ✨🔹 Tomorrow marks the culmination of months of hard work, collaboration, and dedication as we gather for the much-awaited event: CE Sunday - a symposium aimed at shaping the future of pharmacy practice! From envisioning to executing, it's been an incredible journey bringing together pharmacists, experts, and industry leaders under one roof. As the organizer, I couldn't be prouder of the lineup we've curated and the discussions we're set to ignite. 🌟 Join us for a day filled with: 🔸 Cutting-edge insights: Dive deep into the latest trends and advancements shaping the pharmaceutical landscape. 🔸 Dynamic discussions: Engage in thought-provoking conversations on critical issues and emerging opportunities in pharmacy practice. 🔸 Networking galore: Connect with fellow professionals, build meaningful relationships, and explore collaboration possibilities. Whether you're a seasoned pharmacist, a budding professional, or an industry enthusiast, CE Sunday promises to inspire, educate, and empower us all to elevate our practice and make a difference in patient care. I extend my heartfelt gratitude to our sponsors, speakers, attendees, and everyone who has contributed to making CE Sunday a reality. Together, we are driving innovation, pushing boundaries, and redefining the future of pharmacy. Let's make tomorrow a day to remember! See you at CE Sunday! 🚀💊 #CESunday #PharmacyInnovation #ElevatePractice

📣 More insights from EPHA's 6th #AccesstoMedicines Forum. Have you heard about the "Fair pricing calculator"? Anne Hendrickx, Advisor in the Research department of Solidaris Wallonie, speaking as a member of AIM - Association Internationale de la Mutualité/International Association of Mutuals explains. The ‘fair pricing calculator’ is a tool designed to help healthcare stakeholders or anybody interested in the matter to calculate a fair price⚖️for new or existing medicines (without generic competition) and compare it to the price paid or being negotiated. More importantly, it is a hands-on tool with clear proposals for data components to contribute to European and international debates about #fairpricing and the #transparency of R&D costs of medicines🔍💊. Hendrickx emphasizes that transparency on R&D costs is key to negotiating a “fair” price for all parties.

Reflecting on an intense Day 3 at #MEDICA2023 and COMPAMED, where fruitful conversations and unexpected synergies unfolded over a beer. Wishing everyone a successful rest of this business-week, safe travels, and a relaxing weekend. Until 2024, "Tschüss Düsseldorf"! 👋 #BiomedConsult #Consultancy #Laboratory #Diagnostics #Development #MedicalProducts

My perspective is that equity is a journey that requires commitment and a power shift, not a quick fix. I'm eager to share more during the next HBA roundtable around co-creating equity. #Equitable_Leadership #Diversity #Equity and #Inclusion

The topic for this week’s The Kinetix Group-Powered by Petauri™ PACT Executive Briefing is, “Pharmacist Collaborative Practice Agreements (CPAs).” All 50 states now allow pharmacists and physicians to enter into Collaborative Practice Agreements (CPAs) in which one or more pharmacists establish a formal relationship with a prescriber, in which the prescriber can delegate specific tasks to a pharmacist under negotiated conditions, which would not otherwise be permitted under the pharmacist’s normal scope of practice Although state laws vary, generally, CPAs allow prescribers to delegate specific patient care tasks to pharmacists. The pharmacist’s scope of practice under a CPA is generally defined by established protocols that are condition or disease specific. For example, under a CPA, pharmacists may be empowered to perform patient assessments, order laboratory tests, prescribe drugs, counsel patients, and make referrals for related care. They may also be permitted to select, initiate, monitor, continue, discontinue, adjust, and refill ongoing therapy regimens. Expanding a pharmacist’s traditional scope of practice through CPAs may open up unique opportunities for life science companies to improve access to therapy, address health equity concerns, and allow for better care coordination among multiple care providers and in complex patient situations. Check out The Kinetix Group-Powered by Petauri™ growing library of TKG PACT Executive Briefings where you can listen and download the companion PDF infographics. https://lnkd.in/evZKhgre #Market_Access, #TKG, #TKGPACT, #Pharmacist_CPA, #Collaborative_Practice_Agreement, #Pharmacist, #Specialty_Pharmacy, #Pharmacy, #Medication

Here are some valuable practical pointers for medical affairs and product development professionals.

🎉 At Posos, we have successfully encoded our entire medicinal database by integrating IDMP standards, marking a significant milestone in our journey towards global interoperability and augmented clinical decision support. 💡 The IDMP ensures that any medicine, and what it contains, can be accurately identified anywhere in Europe and indeed globally. This is crucial for preventing critical issues such as avoiding negative drug-drug interactions, assisting physicians and pharmacists in making substitution decisions or fighting drug falsification. In line with this endeavor, our pharmacists Marick ESBERARD, Eric Ros, and Vincent Gomez, attended the UNICOM - Up-scaling the global univocal identification of medicines conference last week. 💪 Posos is proud to contribute to the transition towards global IDMP standards adoption, ensuring seamless integration between databases across the world. #Interoperability #IDMP #eprescribing